Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs (opens in new tab)

Covered by 7 sources including reason.com, The Guardian

New ethics disclosures show the president invested in Eli Lilly and a company that manufactures injectable devices as his health agencies implemented policies that benefited them.

Read the original article

Sign in to keep reading the full article.

Sign Up Log In

Covered in 7 articles

reason.com·

Trump's Corruption Is Brazen, Obvious, and Costly. Will Enough Republicans Try To Stop Him?

The Guardian·

Trades of Eli Lilly shares were made on Trump’s behalf as drugmaker benefitted from his policies

STAT·

STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more

View all 7 ›